Abstract:Cortex Lycii, as a kind of traditional Chinese medicines, have shown prospects in the prevention of diabetes and its complications. However, there is comparatively little information regarding the characterization of potentially hypoglycemic compounds derived from Cortex Lycii. In this study, we performed a global non-selective investigation of α-glucosidase inhibitors in Cortex Lycii based on a bioactivity-labeling high-resolution mass spectrometry–metabolomics method. Samples of Cortex Lycii were collected from different Chinese provinces and their ethyl acetate extracts were analyzed using an in vitro α-glucosidase inhibition assay for bioactivity-labeling. The ethyl acetate extracts were also subjected to liquid chromatography-mass spectrometry analysis and multivariate data analysis was subsequently conducted to identify correlations between the bioactivity measured from the enzyme-involved test and the profiles obtained based on high-resolution mass spectrometry. The variables contributing significantly to the separation of the more-active from the less-active samples were considered to indicate the potential target ions of active compounds. MS/MS fragment patterns and nuclear magnetic resonance analyses were used to identify the potential target ions. The developed platform mentioned above facilitated rapid identification of four α-glucosidase inhibitors, namely, N-p-trans-coumaroyltyramine (1), N-trans-caffeoyl-tyramine (2), (9R,10E,12Z)-9-hydroxy-10,12-octadecadienoic acid (3a), and (9S,10E,12Z)-9-hydroxy-10,12-octadecadienoic acid (3b) from Cortex Lycii. The α-glucosidase inhibitory activities of compounds 3a and 3b with IC50 values of 1.0413±0.0551 and 1.0423±0.0049 mM, respectively, are reported here for the first time. Enzyme kinetics revealed that both 3a and 3b were non-competitive inhibitors of α-glucosidase, with Ki values of 2.20 and 2.24 mM, respectively. In short, the presented work identified compounds 3a and 3b as potential α-glucosidase inhibitors with higher inhibitory activity and a different mode of inhibition compared to the standard α-glucosidase inhibitor, acarbose. The integrated approach adopted in this study can be extended as a normalized procedure to rapidly identify active compounds, even from complex extracts, and can readily be adapted for the study of other natural products.

Application of Metabonomic Strategy to Discover an Unreported Active Ingredient in LiuWeiDiHuang Pills Suppressing Beta-Glucuronidase.

Comprehensive Profiling of Lingzhihuang Capsule by Liquid Chromatography Coupled with Mass Spectrometry-Based Molecular Networking and Target Prediction

Efficient Screening of Pancreatic Lipase Inhibitors from Rheum Palmatum by Affinity Ultrafiltration-High-performance Liquid Chromatography Combined with High-Resolution Inhibition Profiling

Development of Rat Urinary HPLC-UV Profiling for Metabonomic Study on Liuwei Dihuang Pills

Integration of Deep Learning and Sequential Metabolism to Rapidly Screen Dipeptidyl Peptidase (DPP)-IV Inhibitors from Gardenia jasminoides Ellis

Metabolite profiling of traditional Chinese medicine formula Dan Zhi Tablet: An integrated strategy based on UPLC-QTOF/MS combined with multivariate statistical analysis.

Rapid Screening Natural-Origin Lipase Inhibitors from Hypolipidemic Decoctions by Ultrafiltration Combined with Liquid Chromatography–mass Spectrometry

Identification of nuclear factor-κB inhibitors and β2 adrenergic receptor agonists in Chinese medicinal preparation Fuzilizhong pills using UPLC with quadrupole time-of-flight MS

Chemical fingerprinting of Liuwei Dihuang Pill and simultaneous determination of its major bioactive constituents by HPLC coupled with multiple detections of DAD, ELSD and ESI-MS.

Biological Ingredient Analysis of Traditional Chinese Medicine Preparation Based on High-Throughput Sequencing: the Story for Liuwei Dihuang Wan.

Identification of Α-Glucosidase Inhibitors from Cortex Lycii Based on a Bioactivity-Labeling High-Resolution Mass Spectrometry–metabolomics Investigation

Characterization of Global Metabolic Profile of Zhi-Zi-Hou-Po Decoction in Rat Bile, Urine and Feces after Oral Administration Based on a Strategy Combining LC–MS and Chemometrics

Bioactivity-integrated Ultra-Performance Liquid Chromatography/quadrupole Time-of-flight Mass Spectrometry for the Identification of Nuclear Factor-Κb Inhibitors and Β2 Adrenergic Receptor Agonists in Chinese Medicinal Preparation Chuanbeipipa Dropping Pills.

Identification Of Nuclear Factor-Kappa B Inhibitors And Beta(2) Adrenergic Receptor Agonists In Chinese Medicinal Preparation Fuzilizhong Pills Using Uplc With Quadrupole Time-Of-Flight Ms

A simple HPLC method for simultaneous analysis of 7 bioactive constituents for Liuwei Dihuang Pill and its application in quality consistency evaluation

An integrating strategy for systematic profiling of Chinese patent drug's chemicalome and associated metabolome: Huanghou antidiarrhea dropping pills as a case study

Rapid Characterization and Identification of the Chemical Constituents and the Metabolites of Du-Zhi Pill Using Uhplc Coupled with Quadrupole Time-of-Flight Mass Spectrometry

Identification and Determination of the Major Constituents in Traditional Chinese Medicine Longdan Xiegan Pill by HPLC-DAD-ESI-MS

Simultaneous Determination of Eight Bioactive Compounds by LC-MS/MS and Its Application to the Pharmacokinetics, Liver First-Pass Effect, Liver and Brain Distribution of Orally Administrated Gouteng-Baitouweng (GB) in Rats.

An integrated strategy to delineate the chemical and dynamic metabolic profile of Huachansu tablets in rat plasma based on UPLC-ESI-QTOF/MS E

A novel strategy with in vivo characterization, extraction, isolation and activity evaluation for discovery of absorbed anti-inflammatory oligosaccharides from Zhu-Ling decoction